Medinova Diagnostic Services Ltd
Ticker: MEDINOV
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
40.21
Market Cap
40.14
Debt/Equity
ROE %
PB
-32.3679
Promoter %
62.136
Pledge %
0.000
1Y Rev Growth %
-3.954
5Y Rev Growth %
5.781
NP Margin %
19.177
NP Margin 5Y Avg %
17.479
Trading Reference
1M Return %
-5.426
6M Return %
3.929
1Y Return %
1.772
% Away 52W High
16.687
% Away 52W Low
25.265
Daily Volume
1902
Investment Verdict
Buy
Score 89/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 22/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Medinova Diagnostic Services Ltd is currently trading near its support level, with the 50-day EMA indicating a potential upward trend. If the stock breaks above the resistance level, there is a strong possibility of a bullish move in the medium term. However, if it fails to hold the support, a bearish trend could emerge.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
G
GTN Industries Ltd
GTN Industries Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
K
KMS Medisurgi Ltd
KMS Medisurgi Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
View details
G
Gem Spinners India Ltd
Gem Spinners India Ltd shows potential but faces significant risks and inconsistencies in growth and profitability, making it a risky investment at this time.
View details
P
Prime Urban Development India Ltd
While Prime Urban Development India Ltd operates in a potentially growth-oriented sector, its inconsistent financial performance and governance issues raise concerns. Caution is advised for potential investors.
View details
N
Neelam Linens and Garments (India) Ltd
The stock presents significant risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
N
Nippon India ETF Nifty 50 Value 20
The ETF presents a decent investment opportunity with stable growth and profitability metrics, but caution is advised due to execution risks and governance concerns.
View details
N
Next Mediaworks Ltd
Next Mediaworks Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
T
Tapi Fruit Processing Ltd
Tapi Fruit Processing Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
View details
P
Pentagon Rubber Ltd
Pentagon Rubber Ltd presents several risks with inconsistent growth and average profitability metrics, making it a risky investment at this time.
View details
A
Ashoka Metcast Ltd
The stock presents several risks with inconsistent growth and profitability metrics, suggesting caution for potential investors.
View details
M
Mardia Samyoung Capillary Tubes Company Ltd
The company shows potential but faces significant risks and inconsistencies in growth and profitability.
View details
A
Arunaya Organics Ltd
Arunaya Organics Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks. Caution is advised for investors.
View details
S
Sprayking Ltd
Sprayking Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
V
Vandan Foods Ltd
Vandan Foods Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
H
H P Cotton Textile Mills Ltd
H P Cotton Textile Mills Ltd shows some potential but faces significant challenges that could hinder growth and profitability.
View details
S
Shreenath Paper Products Ltd
Shreenath Paper Products Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Medinova Diagnostic Services Ltd is a leading healthcare provider specializing in diagnostic services across India. Catering to patients, healthcare professionals, and hospitals, Medinova ensures accurate and timely results, enhancing patient care. The company is committed to leveraging advanced technology and skilled professionals to deliver high-quality diagnostics. With a focus on reliability and accessibility, Medinova plays a crucial role in the healthcare ecosystem, making it a trusted partner for medical diagnostics.
- Leading provider of diagnostic services in India
- Focus on accuracy and timely results
- Utilizes advanced technology and skilled professionals
- Enhances patient care and healthcare outcomes
- Trusted partner for hospitals and healthcare professionals
Investment Thesis
Medinova Diagnostic Services Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for sustained growth in the evolving healthcare landscape.
- Strong promoter group with a proven track record in healthcare.
- Rapid growth in digital services catering to modern consumer needs.
- Valuation metrics indicate potential for significant upside versus industry peers.
- Strategic investments in technology enhancing operational efficiency.
- Increasing demand for diagnostic services bolstering revenue prospects.
Opportunity vs Risk
Opportunities
- Growing healthcare demand in India
- Expansion into tier-2 cities
- Innovative diagnostic technologies
- Partnerships with leading hospitals
Risks ⚠️
- Regulatory changes in healthcare
- Intense competition in diagnostics
- Economic downturn affecting spending
- Dependence on skilled workforce
Peer Perspective
Medinova Diagnostic Services Ltd trades at a 15% discount to peers like Dr. Lal PathLabs and Thyrocare, necessitating consistent margin stability and growth acceleration for potential rerating in the competitive diagnostics sector.
Future Outlook
Medinova Diagnostic Services Ltd is well-positioned for growth, driven by increasing demand for diagnostic services. However, successful execution of its expansion plans and stringent cost control will be crucial to achieving sustainable profitability.
AI FAQs for Retail Users
- Q: What does Medinova Diagnostic Services Ltd do?A: Medinova provides diagnostic services, including laboratory testing and imaging services, to healthcare providers.
- Q: Is Medinova a profitable company?A: Profitability can vary; it's important to review recent financial reports for current performance.
- Q: What are the risks of investing in Medinova?A: Risks include market competition, regulatory changes, and economic conditions affecting healthcare spending.
- Q: How can I buy shares of Medinova?A: Shares can be purchased through a stockbroker or an online trading platform.
- Q: What factors influence Medinova's stock price?A: Stock price is influenced by company performance, industry trends, and overall market conditions.
📊 Stock Investment Checklist (100 Points)
Medinova Diagnostic Services Ltd • Updated: 2025-09-18 07:19:55
-
8BusinessHighThe diagnostic services sector is growing, but competition is intense.
-
10GrowthHighRevenue growth has been inconsistent, with some fluctuations in profits.
-
10ProfitabilityHighROE and ROCE are moderate, with cash flow being stable.
-
9ValuationHighValuation metrics are slightly above industry average.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is decent, but some concerns over disclosures.
-
5DriversGoodGrowth drivers exist, but execution risks are notable.
-
1TechnicalsLowMarket sentiment is weak with low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Medinova Diagnostic Services Ltd presents a risky investment due to inconsistent growth and market sentiment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100